Dr. Jakob von Moltke receives 2017 NIH Director's New Innovator award

The NIH Director's New Innovator Award is part of the High-Risk, High-Reward Research program, the award supports exceptionally creative early career investigators who propose innovative, high-impact projects.

Dr. Jakob von Moltke's work focuses on parasitic worms (helminths) and allergens which both induce a “type 2” immune response, however very little is known about how the immune system first senses these agonists. The Moltke lab aims to uncover how intestinal tuft cells detect helminth infection, thereby employing an entirely new and innovative entry point to understanding type 2 immune sensing. If successful, this work would establish a novel paradigm for the initiation of type 2 immune responses and could provide new targets for therapeutic intervention in helminth infection and allergy. 

Read more about the Moltke Lab project: Sensing of Helminths by Tuft Cells.

   

More About the NIH Director's New Innovator Award

NIH Director's New Innovator Award

The NIH Director's New Innovator Award, established in 2007, supports unusually innovative research from early career investigators who are within 10 years of their final degree or clinical residency and have not yet received a research project grant or equivalent NIH grant.